We are live on
!
Find out more
GPCM
Granite Point Capital Management Portfolio holdings
AUM
$4.9M
1-Year Est. Return
38.41%
This Fund
S&P 500
This Quarter
Est. Return
+20.33%
1 Year Est. Return
+38.41%
3 Year Est. Return
+124.67%
5 Year Est. Return
+295.96%
10 Year Est. Return
–
AUM
$335M
AUM Growth
+$209M
(+167%)
Cap. Flow
+$192M
Cap. Flow
% of AUM
57.49%
Top 10 Holdings %
Top 10 Hldgs %
71.15%
Holding
117
New
37
Increased
8
Reduced
35
Closed
31
Top Buys
| 1 |
TELL
Tellurian Inc.
TELL
|
+$34.5M |
| 2 |
HIMX
Himax Technologies
HIMX
|
+$9.04M |
| 3 |
Lumentum
LITE
|
+$3.32M |
| 4 |
Advanced Micro Devices
AMD
|
+$3.02M |
| 5 |
WMGI
Wright Medical Group Inc
WMGI
|
+$2.98M |
Top Sells
| 1 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
+$5.8M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$4.12M |
| 3 |
Teekay
TK
|
+$3.06M |
| 4 |
MB
MINDBODY, Inc. Class A Common Stock
MB
|
+$2.57M |
| 5 |
AERI
Aerie Pharmaceuticals
AERI
|
+$2.21M |
Sector Composition
| 1 | Technology | 11.01% |
| 2 | Energy | 8.96% |
| 3 | Healthcare | 7.63% |
| 4 | Communication Services | 4.05% |
| 5 | Consumer Discretionary | 2.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$782B
| $75.4M | 22.54% |
+320,000
| New | +$74.4M |
|
2
PUT
iShares Russell 2000 ETF
IWM
$82.6B
| $57.7M | 17.25% |
+420,000
| New | +$57.4M |
|
|
3
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$782B
| $35.4M | 10.57% |
+150,000
| New | +$34.9M |
|
|
TELL
4
DELISTED
Tellurian Inc.
TELL
| $29.2M | 8.71% |
+2,674,566
| New | +$34.5M |
|
|
HIMX
5
Himax Technologies
HIMX
$2.25B
| $12.2M | 3.64% |
+1,335,000
| New | +$9.04M |
|
6
CALL
Apple
AAPL
$4.89T
| $8.62M | 2.58% |
+240,000
| New | +$7.9M |
|
|
HIMX
7
CALL
Himax Technologies
HIMX
$2.25B
| $6.74M | 2.01% |
738,500
+188,500
| +34% | +$1.28M |
|
8
Meta Platforms (Facebook)
META
$1.69T
| $4.73M | 1.41% |
33,300
-9,100
| -21% | -$1.22M |
|
|
ADMS
9
DELISTED
Adamas Pharmaceuticals
ADMS
| $4.12M | 1.23% |
235,515
-20,516
| -8% | -$350K |
|
|
10
Lumentum
LITE
$54.9B
| $4.02M | 1.2% |
+75,300
| New | +$3.32M |
|
11
PUT
iShares MSCI Emerging Markets ETF
EEM
$28.4B
| $3.94M | 1.18% |
+100,000
| New | +$3.8M |
|
|
AERI
12
DELISTED
Aerie Pharmaceuticals
AERI
| $3.85M | 1.15% |
84,959
-49,541
| -37% | -$2.21M |
|
|
NVRO
13
DELISTED
NEVRO CORP.
NVRO
| $3.47M | 1.04% |
37,000
-13,000
| -26% | -$1.18M |
|
|
14
Advanced Micro Devices
AMD
$817B
| $3.46M | 1.03% |
+238,000
| New | +$3.02M |
|
|
WMGI
15
DELISTED
Wright Medical Group Inc
WMGI
| $3.42M | 1.02% |
+110,000
| New | +$2.98M |
|
16
Shake Shack
SHAK
$2.39B
| $3.34M | 1% |
100,000
-50,001
| -33% | -$1.73M |
|
17
JPMorgan Chase
JPM
$912B
| $3.21M | 0.96% |
36,550
-10,450
| -22% | -$922K |
|
18
Axogen
AXGN
$2.12B
| $3.13M | 0.94% |
299,561
-52,439
| -15% | -$535K |
|
19
STMicroelectronics
STM
$56B
| $2.86M | 0.85% |
185,000
+85,000
| +85% | +$1.18M |
|
|
SBBP
20
DELISTED
Strongbridge Biopharma plc.
SBBP
| $2.83M | 0.84% |
595,029
-11,578
| -2% | -$35.5K |
|
21
Amazon
AMZN
$2.69T
| $2.46M | 0.74% |
55,500
-46,000
| -45% | -$1.92M |
|
22
Bank of America
BAC
$432B
| $2.44M | 0.73% |
103,500
-21,500
| -17% | -$510K |
|
23
NetEase
NTES
$83.4B
| $2.3M | 0.69% |
40,500
-23,375
| -37% | -$1.26M |
|
24
Alphabet (Google) Class A
GOOGL
$4.33T
| $2.12M | 0.63% |
+50,000
| New | +$2.1M |
|
|
ZYNE
25
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $1.99M | 0.59% |
+99,000
| New | +$1.97M |
|
Similar funds
MAM
CCM
BGCI
CAM
EAM
SM
TPL
RC
Granite Point Capital Management's Q1 2017 Portfolio in Review
As of Q1 2017, Granite Point Capital Management held 117 positions worth $335M, up 167% from $125M the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Granite Point Capital Management deployed $192M of net new capital in Q1 2017, opening 37 new positions and adding to 8 existing holdings. Its largest new stake was Tellurian Inc.: 2,674,566 shares worth $29.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Teekay, an estimated $3.06M trimmed.
- Granite Point Capital Management's largest Q1 2017 buy was Tellurian Inc.: 2,674,566 shares worth $29.2M.
- Granite Point Capital Management added most to STMicroelectronics in Q1 2017, an estimated $1.18M increase.
- Granite Point Capital Management's biggest Q1 2017 reduction was Teekay, cutting an estimated $3.06M.
- Granite Point Capital Management fully exited Ariad Pharmaceuticals Inc in Q1 2017, selling an estimated $5.8M.
- Granite Point Capital Management's ten largest holdings make up 71% of its $335M portfolio in Q1 2017.
- Granite Point Capital Management opened 37 new positions and closed 31 in Q1 2017.
- Granite Point Capital Management's portfolio value rose 167% quarter-over-quarter to $335M.
Based on Granite Point Capital Management's 13F filing for Q1 2017, filed 10 May 2017.